Related Articles
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway Corrigendum in /10.3892/or.2023.8602
Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A
Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma
Role of triosephosphate isomerase and downstream functional genes on gastric cancer